Explainer

ADHD and Anxiety: Why They Overlap and How They're Treated

39% of U.S. children with ADHD also had anxiety in 2022, and 47% of adults with ADHD had an anxiety disorder. Why the two overlap and how they're treated.

Mental Health Stats Research Team 6 min read

Key Takeaways

  • In 2022, 39.1% of U.S. children aged 3 to 17 with current ADHD also had anxiety, based on a national parent survey[1].39.1%[1]
  • Among U.S. adults aged 18 to 44 with ADHD, 47.1% had an anxiety disorder in the past 12 months, compared with 19.5% of adults without ADHD[2].47.1%[2]
  • Generalized anxiety disorder requires hard-to-control worry for at least 6 months, and two of its six listed symptoms, restlessness and trouble concentrating, resemble ADHD[3].6 months[3]
  • Across 23 placebo-controlled trials with 2,959 children, stimulants were linked to a lower risk of reported anxiety than placebo, with a relative risk of 0.86[4].0.86[4]
  • The American Academy of Pediatrics' 2019 guideline recommends that clinicians at least screen for anxiety and other coexisting conditions when evaluating a child for ADHD[5].2019[5]
How these numbers are measured: Child figures are parent-reported from a 2022 national survey[1]. Adult figures come from the National Comorbidity Survey Replication, published in 2006, which screened a probability subsample of 3,199 adults aged 18 to 44 using DSM-IV definitions[2]. Those definitions counted PTSD and obsessive-compulsive disorder as anxiety disorders, so the adult anxiety totals include them.

ADHD and Anxiety: How Often They Occur Together

ADHD and anxiety frequently occur together in both children and adults. In a 2022 national parent survey, 39.1% of U.S. children aged 3 to 17 with current ADHD also had anxiety[1].

Anxiety was the second most common co-occurring condition in that survey, behind behavior or conduct problems at 44.1%[1]. Overall, 77.9% of children with ADHD had at least one other condition[1].

Adults show a similar pattern. In the National Comorbidity Survey Replication, 47.1% of adults aged 18 to 44 with ADHD had an anxiety disorder in the past 12 months, compared with 19.5% of those without ADHD, an odds ratio of 3.7[2].

The overlap runs in both directions. Among adults with any anxiety disorder, 9.5% met criteria for ADHD, against 2.8% of adults without an anxiety disorder[2].

Social phobia was the most common anxiety disorder among adults with ADHD, at 29.3% versus 7.8% of other adults[2]. Agoraphobia showed the strongest association, with an odds ratio of 5.5[2].

How many people have either condition is a separate question. It is tracked on the ADHD statistics page, the anxiety statistics page and in How Many People Have ADHD?

U.S. children with current ADHD who also had anxiety, 2022
39.1%

Roughly 4 in 10 children with ADHD had co-occurring anxiety, based on parent reports. CDC also reports that children with ADHD plus another condition more often had severe ADHD.

"About 4 in 10 of the children with ADHD had anxiety."

Centers for Disease Control and Prevention(2026) View Source

Anxiety Disorders Among U.S. Adults With and Without ADHD

12-month disorderAdults with ADHDAdults without ADHDOdds ratio
Any anxiety disorder47.1%19.5%3.7
Social phobia29.3%7.8%4.9
Specific phobia22.7%9.5%2.8
PTSD11.9%3.3%3.9
Panic disorder8.9%3.1%3.0
Generalized anxiety disorder8.0%2.6%3.2
Agoraphobia4.0%0.7%5.5
Obsessive-compulsive disorder2.7%1.3%1.5

Share of U.S. adults aged 18 to 44 with each DSM-IV anxiety disorder in the past 12 months, by ADHD status. National Comorbidity Survey Replication, published 2006 [2].

1Odds ratios are adjusted for age. All differences are statistically significant except obsessive-compulsive disorder (95% CI 0.2 to 9.4).

2DSM-IV grouped PTSD and obsessive-compulsive disorder with the anxiety disorders.

Sources

  • •Kessler RC, et al. American Journal of Psychiatry, 2006

Why Do ADHD and Anxiety Occur Together?

Researchers have not settled whether ADHD leads to anxiety, anxiety worsens ADHD, or both share common roots. The survey figures above show an association, not a cause.

Shared genetic risk is one explanation with evidence behind it. A study of all 3,475,112 adults in Sweden, which compared diagnoses among full and half siblings, found that a general genetic factor influenced eight psychiatric conditions, including ADHD and anxiety[6].

That general factor accounted for 10% of the variance in ADHD, the smallest share among the conditions studied, and 36% for drug abuse, the largest[6]. Genes shared across many disorders are therefore only part of the picture.

A second explanation is that anxiety partly follows from uncontrolled ADHD symptoms. The authors of a 2015 stimulant meta-analysis proposed that anxiety may improve as a secondary effect of better ADHD symptom control[4], and the AAP guideline notes that treating ADHD may improve coexisting anxiety symptoms in some cases[5].

Neither line of evidence fixes the direction. The U.S. adult survey measured both conditions at one point in time and assessed childhood ADHD retrospectively, so it cannot show which came first[2].

Generalized anxiety disorder (GAD)

An anxiety disorder diagnosed when a person finds it difficult to control worry on most days for at least 6 months and has at least three of these symptoms: feeling restless or on edge, fatigue, trouble concentrating, irritability, muscle tension, or sleep problems[3].

Related Terms

anxiety disorder
social anxiety disorder
comorbidity

Source: National Institute of Mental Health, 2025

ADHD vs. Anxiety: How Clinicians Tell Them Apart

Anxiety can look like ADHD. CDC lists anxiety, depression, sleep disorders and some learning disabilities among the problems that can cause ADHD-like symptoms, and there is no single test that diagnoses ADHD[7].

Part of the overlap is built into the diagnostic criteria. Restlessness and trouble concentrating are two of the six listed symptoms of generalized anxiety disorder[3], and they resemble the hyperactivity and inattention that define ADHD[7].

Timing and content help separate them. DSM-5 requires some inattentive or hyperactive-impulsive symptoms before age 12 for an ADHD diagnosis[5], while GAD centers on hard-to-control worry lasting at least 6 months[3].

For children, the AAP recommends that providers ask parents, teachers and other adults about behavior at home, at school and with peers, and check whether another condition better explains the symptoms[7].

Age shapes how GAD shows up. NIMH notes that GAD usually starts in early adulthood, and that worries in children and teens with GAD often center on school, friendships and the future, sometimes with a push for perfection[3].

Both diagnoses can apply at once. The AAP's 2019 guideline tells primary care clinicians to at least screen for anxiety and other coexisting conditions during an ADHD evaluation, a Grade B, strong recommendation[5]. How screening tools and evaluations work is covered in ADHD Test.

Where ADHD and Generalized Anxiety Disorder Overlap

FeatureGeneralized anxiety disorderADHD
Core problemWorry that is hard to controlInattention, hyperactivity or impulsivity
Timing ruleMost days for at least 6 monthsSome symptoms before age 12
RestlessnessListed symptomPart of hyperactivity
Trouble concentratingListed symptomPart of inattention
Fatigue, irritability, muscle tension, sleep problemsListed symptomsNot core ADHD domains

Diagnostic features of generalized anxiety disorder and ADHD as described by NIMH (2025), the American Academy of Pediatrics (2019) and CDC (2026) [3, 5, 7].

1GAD diagnosis also requires at least three of its six listed symptoms.

2ADHD's core domains are inattention, hyperactivity and impulsivity.

Sources

  • •NIMH, 2025
  • •American Academy of Pediatrics, 2019
  • •CDC, 2026

Do ADHD Medications Make Anxiety Worse?

Anxiety is commonly reported as a stimulant side effect, but pooled trial data point the other way for most children. A 2015 meta-analysis of 23 double-blind, placebo-controlled trials covering 2,959 children with ADHD found a lower risk of anxiety with stimulants than with placebo: relative risk 0.86 (95% CI 0.77 to 0.95)[4].

In the same analysis, higher stimulant doses were associated with lower measured anxiety risk[4]. The authors noted that the result does not rule out increased anxiety in individual children[4].

The evidence base is thin. A 2022 meta-analytic review found that only 11% of eligible pediatric ADHD drug trials reported anxiety or depression as an outcome or side effect[8]. Among those that did, medication had no significant effect on anxiety symptoms relative to placebo[8].

A non-stimulant has been tested directly in this group. In a 12-week trial of 176 children and teens aged 8 to 17 with ADHD plus generalized, separation or social anxiety disorder, atomoxetine cut ADHD rating-scale scores by 10.5 points versus 1.4 on placebo, and anxiety scores by 5.5 versus 3.2[9].

Almost all of this research is in children and adolescents, so it may not carry over to adults. Drug classes and side effects are covered in ADHD Meds and Anxiety Medication.

How Are ADHD and Anxiety Treated Together?

Once a coexisting condition is found, the AAP guideline gives primary care clinicians two routes: treat it if they are trained to, or refer to a subspecialist[5]. It names severe mood or anxiety disorders as examples that may need subspecialist assessment[5].

The guideline also notes that treating ADHD may improve coexisting anxiety symptoms in some cases, while in others the coexisting condition needs treatment in addition to ADHD care[5].

The NIMH-funded MTA study offers evidence on treatment choice for children. Among 579 children aged 7 to 9.9, those with ADHD and anxiety but no oppositional or conduct disorder responded about equally well to behavioral treatment and to medication[10].

Children with ADHD alone, or ADHD with oppositional or conduct disorders, responded best to medication, and those with both anxiety and conduct problems did best with combined treatment[10]. Behavioral approaches are described in Behavior Therapy for ADHD.

For the anxiety itself, NIMH describes cognitive behavioral therapy as the gold-standard psychotherapy for GAD, with SSRIs, SNRIs, buspirone and short-term benzodiazepines among the medication options[3]. The trial evidence for each is summarized in Therapy for Anxiety and CBT for ADHD.

What the Research on ADHD and Anxiety Doesn't Show Yet

The U.S. adult estimates come from one survey published in 2006, limited to ages 18 to 44 and to DSM-IV definitions[2].

The child estimates rely on parent report rather than clinical interviews[1].

Drug trials rarely track anxiety: only 11% of eligible pediatric trials in the 2022 review reported it[8]. The atomoxetine trial lasted 12 weeks, too short to show long-term effects[9].

Population-level figures sit on the pillar pages, including ADHD in adults, ADHD in children and generalized anxiety disorder.

Frequently Asked Questions

Sources & References

  1. Centers for Disease Control and Prevention. Data on ADHD in Children. CDC. Published 2024. Updated July 2026. Accessed October 2026. https://www.cdc.gov/adhd/data/index.html [Link]
  2. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. American Journal of Psychiatry. Published 2006. Accessed October 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC2859678/ [Link]
  3. National Institute of Mental Health. Generalized Anxiety Disorder: What You Need to Know. NIMH. Published 2025. Accessed October 2026. https://www.nimh.nih.gov/health/publications/generalized-anxiety-disorder-gad [Link]
  4. Coughlin CG, Cohen SC, Mulqueen JM, et al. Meta-analysis: reduced risk of anxiety with psychostimulant treatment in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. Published 2015. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/26402485/ [Link]
  5. Wolraich ML, Hagan JF Jr, Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. Published 2019. Accessed October 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC7067282/ [Link]
  6. Pettersson E, Larsson H, Lichtenstein P. Common psychiatric disorders share the same genetic origin: a multivariate sibling study of the Swedish population. Molecular Psychiatry. Published 2016. Accessed October 2026. https://www.nature.com/articles/mp2015116 [Link]
  7. Centers for Disease Control and Prevention. Diagnosing ADHD. CDC. Published 2024. Updated July 2026. Accessed October 2026. https://www.cdc.gov/adhd/diagnosis/index.html [Link]
  8. Bryant A, Schlesinger H, Sideri A, et al. A meta-analytic review of the impact of ADHD medications on anxiety and depression in children and adolescents. European Child & Adolescent Psychiatry. Published 2022. Accessed October 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC10533622/ [Link]
  9. Geller D, Donnelly C, Lopez F, et al. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. Journal of the American Academy of Child & Adolescent Psychiatry. Published 2007. Accessed October 2026. https://doi.org/10.1097/chi.0b013e3180ca8385 [Link]
  10. Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry. Published 2001. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/11211363/ [Link]

Related Statistics